A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes-Reference-Cited by-同舟云学术

A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes

Published:2022-06-29 Issue:8 Volume:39 Page:3749-3765
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Ferdous Md. Misbahul,Jie Zhao,Gao Lijian,Qiao Shubin,Liu Haibo,Guan Changdong,Hu Fenghuan,Kottu Lakshme,Qian Jie,Yan Hongbin,Luo Tong,Yang Weixian,Qiu Hong,Mao Yi,Sun Zhongwei,Yu Mengyue,Cui Jingang,Xu Bo,Wu Yongjian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-022-02154-w.pdf

Reference21 articles.

1. Pavasini R, Serenelli M, Gallo F, et al. Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. J Thorac Dis. 2017;9:S887–97.

2. Ali ZA, Gao R, Kimura T, et al. Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials. Circulation. 2018;137:464–79.

3. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker- Havinga T, van Es GA, Meier B, Jüni P, Windecker S. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013;6:777–89.

4. Zhang Y, Gao R, Xu B, Cummins P, Serruys PW. Bioresorbable scaffolds for coronary artery disease: current status and future prospective. Chin Med J (Engl). 2014;127:1141–8.

5. Tenekecioglu E, Bourantas C, Abdelghani M, Zeng Y, Silva RC, Tateishi H, Sotomi Y, Onuma Y, Yilmaz M, Serruys PW. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI. Expert Rev Med Devices. 2016;13:271–86.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights and perspectives into biodegradable metals in cardiovascular stents: A mini review;Journal of Alloys and Compounds;2024-10

2. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

3. Epidemiology and current management of cardiovascular disease in China;Journal of Geriatric Cardiology;2024-04

4. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort;Diabetes and Vascular Disease Research;2023-07